BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 16061918)

  • 1. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications.
    Hampel H; Abraham NS; El-Serag HB
    Ann Intern Med; 2005 Aug; 143(3):199-211. PubMed ID: 16061918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.
    Nocon M; Labenz J; Jaspersen D; Meyer-Sabellek W; Stolte M; Lind T; Malfertheiner P; Willich SN
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1728-31. PubMed ID: 17914941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
    Wu YW; Tseng PH; Lee YC; Wang SY; Chiu HM; Tu CH; Wang HP; Lin JT; Wu MS; Yang WS
    PLoS One; 2014; 9(3):e92001. PubMed ID: 24642729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between obesity and GERD: a review of the epidemiological evidence.
    El-Serag H
    Dig Dis Sci; 2008 Sep; 53(9):2307-12. PubMed ID: 18651221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Multimodality Imaging in Gastroesophageal Reflux Disease and Its Complications, with Clinical and Pathologic Correlation.
    Manning MA; Shafa S; Mehrotra AK; Grenier RE; Levy AD
    Radiographics; 2020; 40(1):44-71. PubMed ID: 31917657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
    El-Serag HB; Graham DY; Satia JA; Rabeneck L
    Am J Gastroenterol; 2005 Jun; 100(6):1243-50. PubMed ID: 15929752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants.
    Mäntynen T; Färkkilä M; Kunnamo I; Mecklin JP; Juhola M; Voutilainen M
    Am J Gastroenterol; 2002 Oct; 97(10):2524-9. PubMed ID: 12385433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus.
    Cook MB; Greenwood DC; Hardie LJ; Wild CP; Forman D
    Am J Gastroenterol; 2008 Feb; 103(2):292-300. PubMed ID: 17986313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.
    Kubo A; Corley DA
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):872-8. PubMed ID: 16702363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does physical activity protect against the development of gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma? A review of the literature with a meta-analysis.
    Lam S; Hart AR
    Dis Esophagus; 2017 Nov; 30(11):1-10. PubMed ID: 28881908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis.
    Singh S; Sharma AN; Murad MH; Buttar NS; El-Serag HB; Katzka DA; Iyer PG
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1399-1412.e7. PubMed ID: 23707461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in relation to Barrett's esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink.
    Drahos J; Li L; Jick SS; Cook MB
    Cancer Epidemiol; 2016 Jun; 42():9-14. PubMed ID: 26972225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
    Lagergren J; Bergström R; Lindgren A; Nyrén O
    N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between body mass and adenocarcinoma of the esophagus and gastric cardia.
    Lagergren J; Bergström R; Nyrén O
    Ann Intern Med; 1999 Jun; 130(11):883-90. PubMed ID: 10375336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is associated with higher prevalence of gastroesophageal reflux disease and reflux related complications: A global healthcare database study.
    Xie M; Deng L; Fass R; Song G
    Neurogastroenterol Motil; 2024 Apr; 36(4):e14750. PubMed ID: 38297487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Evaluation and Management of Suspicious Gastric Lesions Following Bariatric Surgery.
    Gomez G
    Surg Clin North Am; 2017 Apr; 97(2):467-474. PubMed ID: 28325198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GERD and its complications. The pathogenic relationship between symptoms and disease progression.
    Pisegna JR
    Postgrad Med; 2001 Oct; Spec No():19-23. PubMed ID: 11868427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma.
    Veugelers PJ; Porter GA; Guernsey DL; Casson AG
    Dis Esophagus; 2006; 19(5):321-8. PubMed ID: 16984526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Increased incidence of adenocarcinoma of the esophagus and cardia. Reflux and obesity are strong and independent risk factors according to the SECC study].
    Lagergren J
    Lakartidningen; 2000 Apr; 97(16):1950-3. PubMed ID: 10826353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.